N-(3-methoxyphenyl)-N-methyl-7-(pyridin-4-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxamide

ID: ALA4786908

PubChem CID: 162667349

Max Phase: Preclinical

Molecular Formula: C23H23N3O3

Molecular Weight: 389.46

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(N(C)C(=O)N2CCOc3ccc(-c4ccncc4)cc3C2)c1

Standard InChI:  InChI=1S/C23H23N3O3/c1-25(20-4-3-5-21(15-20)28-2)23(27)26-12-13-29-22-7-6-18(14-19(22)16-26)17-8-10-24-11-9-17/h3-11,14-15H,12-13,16H2,1-2H3

Standard InChI Key:  YKSNUQNFEPMXPI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   30.3667  -21.5689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3656  -22.3884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0736  -22.7974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0718  -21.1600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6595  -22.7967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9518  -22.3858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2442  -22.7932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2431  -23.6113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9555  -24.0203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6601  -23.6106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7853  -22.3855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7805  -21.5653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4214  -21.0443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4353  -22.8951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2259  -21.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2383  -22.7039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5872  -21.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7546  -23.3373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4642  -24.1012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.5613  -23.2069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0776  -23.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7845  -24.6027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3001  -25.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1077  -25.1056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3972  -24.3369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8797  -23.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2034  -24.2036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.7220  -24.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8517  -22.4430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3 11  2  0
 12  4  2  0
  4  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  2  5  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 13 15  1  0
 14 16  1  0
 15 17  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 27 28  1  0
 20 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4786908

    ---

Associated Targets(Human)

GPR142 Tchem Probable G-protein coupled receptor 142 (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr142 Probable G-protein coupled receptor 142 (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.46Molecular Weight (Monoisotopic): 389.1739AlogP: 4.21#Rotatable Bonds: 3
Polar Surface Area: 54.90Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.16CX LogP: 2.86CX LogD: 2.85
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.31

References

1. Wilson JE,Kurukulasuriya R,Sinz C,Lombardo M,Bender K,Parker D,Sherer EC,Costa M,Dingley K,Li X,Mitelman S,Tong S,Bugianesi R,Ehrhardt A,Priest B,Ratliff K,Ujjainwalla F,Nargund R,Hagmann WK,Edmondson S.  (2016)  Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes.,  26  (12.0): [PMID:27240550] [10.1016/j.bmcl.2016.04.018]

Source